Citadel Advisors
OFIX icon

Citadel Advisors’s Orthofix Medical OFIX Stock Holding History

Citadel Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,900
Closed -$160K – 13670
2025
Q3 		$160K Buy
+10,900
New +$143K ﹤0.01% 11489
2025
Q2 		– Sell
-2,200
Closed -$35.9K – 14319
2025
Q1 		$35.9K Buy
2,200
+1,800
+450% +$31.6K ﹤0.01% 12637
2024
Q4 		$6.98K Buy
400
+300
+300% +$5.22K ﹤0.01% 13769
2024
Q3 		$1.56K Sell
100
-3,700
-97% -$59.3K ﹤0.01% 13836
2024
Q2 		$50.4K Sell
3,800
-700
-16% -$9.59K ﹤0.01% 11751
2024
Q1 		$65.3K Buy
+4,500
New +$62.2K ﹤0.01% 11898
2023
Q3 		– Sell
-300
Closed -$5.42K – 14850
2023
Q2 		$5.42K Hold
300
– – ﹤0.01% 13502
2023
Q1 		$5.03K Buy
300
+100
+50% +$1.96K ﹤0.01% 13902
2022
Q4 		$4.11K Buy
+200
New +$3.53K ﹤0.01% 14133
2022
Q1 		– Sell
-6,700
Closed -$208K – 14289
2021
Q4 		$208K Buy
+6,700
New +$224K ﹤0.01% 11769
2019
Q3 		– Sell
-6,000
Closed -$317K – 9592
2019
Q2 		$317K Sell
6,000
-13,600
-69% -$723K ﹤0.01% 7499
2019
Q1 		$1.11M Sell
19,600
-8,100
-29% -$455K ﹤0.01% 5407
2018
Q4 		$1.45M Buy
27,700
+10,700
+63% +$609K ﹤0.01% 4687
2018
Q3 		$983K Sell
17,000
-500
-3% -$28K ﹤0.01% 5577
2018
Q2 		$994K Buy
17,500
+2,400
+16% +$137K ﹤0.01% 5222
2018
Q1 		$888K Buy
15,100
+10,000
+196% +$560K ﹤0.01% 5000
2017
Q4 		$279K Buy
+5,100
New +$264K ﹤0.01% 6579
2015
Q4 		– Sell
-4,000
Closed -$135K – 9043
2015
Q3 		$135K Sell
4,000
-1,500
-27% -$53.4K ﹤0.01% 6637
2015
Q2 		$182K Buy
5,500
+3,700
+206% +$127K ﹤0.01% 6440
2015
Q1 		$65K Sell
1,800
-3,000
-63% -$94.3K ﹤0.01% 7206
2014
Q4 		$144K Buy
4,800
+1,700
+55% +$49.8K ﹤0.01% 6323
2014
Q3 		$96K Buy
+3,100
New +$103K ﹤0.01% 6444

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Citadel Advisors's OFIX Position: Q2 2026 in Review

Citadel Advisors reduced its Orthofix Medical (OFIX) stake by 61% in Q2 2026, selling an estimated $849K and leaving 49,418 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #10110.

Citadel Advisors first reported a position in OFIX in Q2 2013 and has held it in 48 quarters since. The position peaked at $7.35M in Q4 2018. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Citadel Advisors held 49,418 shares of Orthofix Medical worth $452K as of Q2 2026.
  • Citadel Advisors sold 76,985 Orthofix Medical shares in Q2 2026, an estimated $849K.
  • Orthofix Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10110 holding.
  • Citadel Advisors first reported a position in Orthofix Medical in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Orthofix Medical position peaked at $7.35M in Q4 2018.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.